13
Views
4
CrossRef citations to date
0
Altmetric
Article

Status of pretreatment evaluation, treatment and follow‐up regimens for renal cell carcinoma in the Nordic countries

, , , , , & show all
Pages 401-407 | Received 09 Sep 2002, Accepted 22 Jan 2003, Published online: 09 Jul 2009

  • Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, et al. Cancer of the kidney: causes, occur-rence and control. IARC Sci Publ 1990; 100: 78–9.
  • Engeland A, Haldorsen T, Tretli S, Bakulinen T, Horte LG, Luostarinen T, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1993; 38: 90–5.
  • Belldegrun A, deKemion JB In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, eds. Campbell's urology, 7th edn. Philadelphia PA: Saunders, 1998: 2283–326.
  • Ritchie AW, Chisholm GD. Management of renal carcinoma—a questionnaire survey. Br J Urol 1983; 55: 591–4.
  • Lang EK. Comparison of dynamic and conventional computed tomography, angiography and ultrasonogra-phy in the staging of renal cell carcinoma. Cancer 1984; 54: 2205–14.
  • Brierly RD, Thomas PJ, Harrison NW, Fletcher MS, Nawrocki JD, Ashton-Key M. Evaluation of fine-needle aspiration cytology for renal masses. BJU Int 2000; 85: 14–8.
  • Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988; 6: 1736–45.
  • Bower M, Ma R, Savage P, Abel P, Waxman J. British urological surgery practice. 2. Renal, bladder and testis cancer. Br J Urol 1998; 81: 513–7.
  • Yonover PM, Flanigan RC. Should radical nephrectomy be performed in the face of surgically incurable disease? Curr Opin Urol 2000; 10: 429–34.
  • Ljungberg B, Landberg G, Alamdari Fl. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2000; 34: 246–51.
  • Mickisch GH, Garin A, van Poppel H, de Prijek L, Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966–70.
  • Dutcher JP. Immunotherapy: are we making a differ-ence? Curr Opin Urol 2000; 10: 435–9.
  • Ljungberg B, Alamdari Fl, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999; 84: 405–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.